Literature DB >> 869143

Anaesthesia and blood loss in total hip replacement.

I Keith.   

Abstract

Twenty-seven consecutive patients scheduled for total hip replacement were randomly divided into three groups. The first group had their operations under epidural analgesia, the second whilst breathing halothane spontaneously and patients in the third group were anaesthetised using a modified neuroleptoanaesthetic (NLA) technique. Blood lost during the operation was measured by a colorimetric technique. Closed suction drains were used and all blood lost after the operation collected for measurement. Deliberate hypotensive techniques were not employed. The mean operative blood loss of patients who had their operations under epidural anaesthesia was significantly less than that of patients in the other two groups, being 341-6 +/- 59-1 ml (s.e.m.) for the epidural group, 648-4 +/- 58-3 ml (s.e.m.) for the halothane group and 744 +/- 98-9 ml (s.e.m.) for the NLA group. There was no significant difference in the amounts of blood collected by closed suction drainage in any of the three groups and the mean values for total overall blood loss incurred by procedure were 734-1 +/- 40-7 ml (s.e.m.) for the epidural group, 986-3 +/- 94-9 ml (s.e.m.) for the halothane group and 1168-4 +/- 126 ml (s.e.m.) for the NLA group. In this series only 3 of 10 patients (30%) who had their operation under epidural anaesthesia required transfusion with whole blood, compared with 7 of 9 (78%) in the halothane group, and 7 of 8 (87-5%) in the neuroleptoanalgesia group. From this series it is evident that the need for transfusion of whole blood in total hip replacement can be significantly reduced by the use of epidural analgesia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869143     DOI: 10.1111/j.1365-2044.1977.tb09981.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  20 in total

Review 1.  Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.

Authors:  A Rodgers; N Walker; S Schug; A McKee; H Kehlet; A van Zundert; D Sage; M Futter; G Saville; T Clark; S MacMahon
Journal:  BMJ       Date:  2000-12-16

2.  A comparison of spinal and epidural anaesthesia for hip arthroplasty.

Authors:  S Davis; R Erskine; M F James
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

3.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

4.  Retrospective Evaluation of Anaesthesia Techniques for Hip Replacement Operations.

Authors:  Murat Koç; Özlem Saçan; Mehmet Gamlı; Vildan Taşpınar; Aysun Postacı; Emel Fikir; Bayazit Dikmen
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-06-01

5.  General compared with spinal anesthesia for total hip arthroplasty.

Authors:  Bryce A Basques; Jason O Toy; Daniel D Bohl; Nicholas S Golinvaux; Jonathan N Grauer
Journal:  J Bone Joint Surg Am       Date:  2015-03-18       Impact factor: 5.284

Review 6.  Regional vs general anaesthesia in orthopaedics.

Authors:  N Buckley
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

7.  Does regional anaesthesia reduce postoperative morbidity?

Authors:  H Kehlet
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

8.  Early mortality after modern total hip arthroplasty.

Authors:  Michael Aynardi; Luis Pulido; Javad Parvizi; Peter F Sharkey; Richard H Rothman
Journal:  Clin Orthop Relat Res       Date:  2008-10-10       Impact factor: 4.176

9.  Blood loss and transfusion requirements in total joint arthroplasty.

Authors:  A M Clarke; T Dorman; M J Bell
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

10.  Effect of epidural versus general anaesthesia on peroperative blood loss during retropubic prostatectomy.

Authors:  H Hendolin; E Alhava
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.